Impact of Health Care Funding on Compliance and Survival in Patients with Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Single Institution Experience

被引：0
|
作者：
Pasam, Avinash [1 ]
Comeau, Jill [2 ]
Shi, Runhua [1 ]
Devarakonda, Srinivas S. [1 ]
机构：
[1] LSU Hlth Sci Ctr, Dept Hematol Oncol, Shreveport, LA USA
[2] ULM Sch Pharm, Monroe, LA USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients with Chronic Myeloid Leukemia, a Single Institution Experience
    Abu-Tineh, Mohammad
    Ali, Elrazi Awadelkarim A.
    Alshurafa, Awni
    Alhaj, Khalid
    Hailan, Yousef
    Kashgary, Waail Rozi
    Nashwan, Abdulqadir Jeprel
    Yassin, Mohamed A.
    BLOOD, 2021, 138
  • [2] Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jain, Preetesh
    Jabbour, Elias J.
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Takahashi, Koichi
    Pemmaraju, Naveen
    Daver, Naval
    Pierce, Sherry A.
    O'Brien, Susan M.
    Cortes, Jorge E.
    CANCER, 2016, 122 (02) : 238 - 248
  • [3] EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience
    Jabbour, Elias
    Cortes, Jorge
    Nazha, Aziz
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Pierce, Sherry
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    BLOOD, 2012, 119 (19) : 4524 - 4526
  • [4] Impact of Comorbidities on Survival of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
    Engelbrecht, Fernanda F.
    Miranda, Eliana C.
    Delamain, Marcia Torresan
    Duarte, Gislaine Borba
    Souza, Carmino Antonio
    De Paula, Erich V.
    Pagnano, Katia B.
    BLOOD, 2019, 134
  • [5] Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
    Kamal Chamoun
    Hagop Kantarjian
    Rami Atallah
    Graciela Nogueras Gonzalez
    Ghayas C. Issa
    Mary Beth Rios
    Guillermo Garcia-Manero
    Gautam Borthakur
    Farhad Ravandi
    Nitin Jain
    Naval Daver
    Marina Konopleva
    Courtney D. DiNardo
    Tapan Kadia
    Naveen Pemmaraju
    Elias Jabbour
    Jorge Cortes
    Journal of Hematology & Oncology, 12
  • [6] Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
    Chamoun, Kamal
    Kantarjian, Hagop
    Atallah, Rami
    Gonzalez, Graciela Nogueras
    Issa, Ghayas C.
    Rios, Mary Beth
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Ravandi, Farhad
    Jain, Nitin
    Daver, Naval
    Konopleva, Marina
    DiNardo, Courtney D.
    Kadia, Tapan
    Pemmaraju, Naveen
    Jabbour, Elias
    Cortes, Jorge
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [7] Real World Outcomes of Chronic Myeloid Leukemia in Era of Tyrosine Kinase Inhibitors a Single Center Experience
    Naik, Seema G.
    Rakszawski, Kevin L.
    Federici, Elizabeth
    Claxton, David F.
    Rybka, Witold B.
    BLOOD, 2022, 140 : 12225 - 12225
  • [8] Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Gale, Robert Peter
    Goldman, John M.
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 192 - 195
  • [9] Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Kondo, Takeshi
    Matsuki, Eri
    Takaku, Tomoiku
    Watanabe, Naoki
    Yoshida, Chikashi
    Okada, Masaya
    Murai, Kazunori
    Kodama, Takashi
    Takahashi, Naoto
    Kimura, Shinya
    Matsumura, Itaru
    CANCER, 2025, 131 (01)
  • [10] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry A.
    Jabbour, Elias J.
    Cortes, Jorge E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 545 - 552
12345